ArticleHuman vaccines & immunotherapeutics2024

Retrospective analysis of health and economic burden among commercially-insured individuals diagnosed with invasive meningococcal disease in the United States.

Oscar Herrera-Restrepo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.